Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Melanoma

Free Subscription 25.08.2025 2 Ann Surg Oncol 2 BMC Ophthalmol 1 Br J Dermatol 2 Cancer Res 2 Clin Cancer Res 1 J Am Acad Dermatol 1 J Invest Dermatol 1 JAMA 2 Nat Med 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. ZAGER JS, John J
   Response to Letter to the Editor Regarding: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.
   Ann Surg Oncol. 2025 Aug 21. doi: 10.1245/s10434-025-18092.
   PubMed        
   
   
2. TAYLOR CD, Niba VS, Baskin AS, Mott NM, et al
   Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma.
   Ann Surg Oncol. 2025 Aug 16. doi: 10.1245/s10434-025-18063.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

3. ROS-SANCHEZ E, Oliver-Gutierrez D, Buck P, Goncharova-Simon T, et al
   Multimodal imaging of tumour-related lipid exudation and exudative retinal detachment following brachytherapy in choroidal melanoma.
   BMC Ophthalmol. 2025;25:467.
   PubMed         Abstract available
   
   
4. KROHN J, Vinnem LIH, Jansson RW, Straume O, et al
   Fundus hypopigmentation and choroidal thinning associated with tebentafusp therapy: report of a case and literature review.
   BMC Ophthalmol. 2025;25:464.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

5. ZHANG WW, Ke LF, Chen Y, Wu CY, et al
   Methylation-Based Test for Diagnosis of Benign and Malignant Melanocytoma.
   Br J Dermatol. 2025 May 2:ljaf169. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Cancer Res

6. FLEM-KARLSEN K, Talty R, McGeary MK, Park K, et al
   Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma that Drives Antitumor Immunity.
   Cancer Res. 2025 Aug 19. doi: 10.1158/0008-5472.CAN-24-1952.
   PubMed         Abstract available
   
   
7. SHAN JL, Zhang KM, Zhong WQ, Yang XY, et al
   Reactivating cGAS-STING Signaling by Targeting SOS1 Enhances Antitumor Immunity in NRAS-Mutant Tumors.
   Cancer Res. 2025;85:3015-3031.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

8. NOH KW, Tolkach Y, Helbig D, Mitchell Barroso V, et al
   Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanoma.
   Clin Cancer Res. 2025 Aug 25. doi: 10.1158/1078-0432.CCR-25-0889.
   PubMed         Abstract available
   
   
9. FA'AK F, Coudray N, Jour G, Ibrahim M, et al
   Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.
   Clin Cancer Res. 2025;31:3526-3536.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

10. SHELTON E, Kaur S, Figueroa Baiges A, Patel J, et al
    Assessing the Protective Role of Sirolimus Against Non-Melanoma Skin Cancer: A Case Series.
    J Am Acad Dermatol. 2025 Aug 15:S0190-9622(25)02600.
    PubMed        
    
    

    
    J Invest Dermatol

11. CHAN AA, Noguti J, Ramirez NM, Navarrete M, et al
    Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence.
    J Invest Dermatol. 2025 Aug 18:S0022-202X(25)02342.
    PubMed         Abstract available
    
    

    
    JAMA

12. JOSHI UM, Kashani-Sabet M, Kirkwood JM
    Cutaneous Melanoma: A Review.
    JAMA. 2025 Aug 25. doi: 10.1001/jama.2025.13074.
    PubMed         Abstract available
    
    

    
    Nat Med

13. KENDRA KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, et al
    Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.
    Nat Med. 2025 Aug 14. doi: 10.1038/s41591-025-03875.
    PubMed         Abstract available
    
    
14. YAN S, Yu Z, Primiero C, Vico-Alonso C, et al
    A multimodal vision foundation model for clinical dermatology.
    Nat Med. 2025;31:2691-2702.
    PubMed         Abstract available
    
    

    
    PLoS One

15. KOSHAREK AT, Zuleger CL, Glass WS, Eickhoff J, et al
    In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma.
    PLoS One. 2025;20:e0330200.
    PubMed         Abstract available
    
    
16. TOLD R, Reumueller A, Kreminger J, Sacu S, et al
    Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis.
    PLoS One. 2025;20:e0328360.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.